Back
Merus NV 10K Form
Sell
29
MRUS
Merus NV
Last Price:
45.50
Seasonality Move:
25.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MRUS News And Ratings
See the #1 stock for the next 7 days that we like better than MRUS
MRUS Financial Statistics
Sales & Book Value
| Annual Sales: | $43.95M |
|---|---|
| Cash Flow: | $-80.69M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $10.28 |
| Price / Book: | 4.43 |
Profitability
| EPS (TTM): | -3.95000 |
|---|---|
| Net Income (TTM): | $-244.56M |
| Gross Margin: | $-24.6M |
| Return on Equity: | -47.97% |
| Return on Assets: | -38.42% |
Merus NV Earnings Forecast
Key Merus NV Financial Ratios
- The Gross Profit Margin over the past 5 years for MRUS is -98.95%.
- The Selling, General & Administrative Expenses for MRUS have been equal to 136.15% of Gross Profit Margin.
- The Research & Development expenses have been 320.06% of Revenue.
- The Interest Expense is -0.19% of Operating Income.
- The Net Earning history of MRUS is -352.56% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 2 years.
Merus NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MRUS |
| CUSIP: | N5749R |
| Website: | merus.nl |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 8.32 |
| Quick Ratio: | 7.94 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |